Pharmaceutical Technology
May 02, 2009
Ingredients Insider
33
5
Strong growth in biopharmaceuticals bodes well for contract manufacturing, but the perils and the promises of pipelines remain.
May 02, 2009
Outsourcing Outlook
33
5
A major CRO ventures further into proprietary drug development.
May 02, 2009
Guest Editorial
33
5
The president of BIO proposes the ingredients needed for industry growth.
May 02, 2009
Agent-In-Place
33
5
Process steps, GMP documents, a purification vessel, and validation seem to disappear.
May 02, 2009
Peer-Reviewed Research
33
5
The authors describe the importance of a rapid and an abbreviated screening strategy by initial solvent screening in 20-mL scintillation vials.
May 02, 2009
News
33
5
The Japanese government is eager to jumpstart its generic-drug market, but changes must come first.
May 02, 2009
Online Exclusive
33
5
Taiwan sees to bring its intellectual property laws and enforcment into better alignment with international standards.
May 02, 2009
Peer-Reviewed Research
33
5
The authors investigate whether the addition of an antioxidant could be used to stabilize the solvent ethyl lactate by preventing the formation of peroxides
May 02, 2009
Inside IPEC
33
5
The GDP committee of IPEC–Europe is trying to seal one more broken link in the supply chain. This article contains bonus online-exclusive material.
May 02, 2009
Special Report
33
5
Taking a cue from its electronics industry, Taiwan is seeking to put its biotechnology and pharmaceutical industries on the map. An interactive map shows pharmaceutical activity in Taiwan.
May 02, 2009
Washington Report
33
5
Government funding is slated to boost comparative studies of prescription drugs.
May 02, 2009
Special Report
33
5
Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.
May 02, 2009
Packaging Forum
33
5
Products at INTERPHEX focused on protection, compliance, and deterring counterfeiting. This article contains bonus online-exclusive material.
May 02, 2009
Viewpoint
33
5
The organizations' presidents discuss market exclusivity, approval processes, and pending legislation.
May 02, 2009
PharmTech Talk
33
5
Technology can solve enterprise-level problems.
May 02, 2009
In the Spotlight
33
5
Editors' Picks of Pharmaceutical Science & Technology Innovations